B cell depletion inhibits spontaneous autoimmune thyroiditis in NOD.H-2h4 mice

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7706-7713

  Yu, Shiguang ^a,b   Dunn, Robert ^c   Kehry, Marilyn R ^c   Braley Mullen, Helen ^a,b,d  

^a Harry S Truman Veterans Affairs Medical Center   (United States)

^b University of Missouri   (United States)

^c BIOGEN   (United States)

^d Department of Internal Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; THYROGLOBULIN ANTIBODY; CD20 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNE THYROIDITIS; B LYMPHOCYTE; BLOOD; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; MALE; MOUSE; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; NONOBESE DIABETIC MOUSE; T LYMPHOCYTE; THYROID GLAND;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED NOD; T-LYMPHOCYTES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 47249089061     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7706     Document Type: Article

References (64)

1. Rasooly, L., C. L. Burek, and N. R. Rose. 1996. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin. Immunol. Immunopathol. 81: 287-292.
2. Braley-Mullen, H., G. C. Sharp, B. Medling, and H. Tang. 1999. Spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 12: 157-165.
3. + T cells are required for iodine accelerated thyroiditis in NOD mice. Cell. Immunol. 192: 113-121.
4. Rose, N. R., R. Bonita, and C. L. Burek. 2002. Iodine: an environmental trigger of thyroiditis. Autoimunm. Rev. 1: 97-103.
5. + T cells in the evolution of iodine-induced thyroiditis in NOD.H-2h4 mice. Eur. J. Immunol. 30: 1191-1202.
6. Yu, S., B. Medling, H. Yagita, and H. Braley-Mullen. 2001. Characteristics of inflammatory cells in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Autoimmun. 16: 37-46.
7. Braley-Mullen, H., and S. Yu. 2000. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 165: 7262-7269.
8. Serreze, D. V., S. A. Fleming, H. D. Chapman, S. D. Richard, E. H. Letter, and R. M. Tisch. 1998. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161: 3912-3918.
9. Noorchashm, H., N. Noorchashm, J. Kem, S. Y. Rostami, C. F. Barker, and A. Naji. 1997. B cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46: 941-946.
10. Chan, O. T., M. P. Madaio, and M. J. Schlomchik. 1999. B cells are required for lupus nephritis in the polygenic. Fas-intact MRL model of systemic autoimmu-nity. J. Immunol. 163: 3592-3596.
11. Saito, E., M. Fujimoto, M. Hasegawa, K. Komura, Y. Hamaguchi, Y. Kaburagi, T. Nagaoka, K. Takehara, T. F. Tedder, and S. Sato. 2002. CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J. Clin. Invest. 109: 1453-1462.
12. Ji, H., K. Ohmura, U. Mahmood, D. M. Lee, F. M. Hofhuis, S. A. Boackle, K. Takahashi, V. M. Holers, M. Walport, C. Gerard, et al. 2002. Arthritis critically dependent on innate immune system. Immunity 16: 157-168.
13. Sanz, I., J. H. Anolik, and R. J. Looney. 2007. B cell depletion therapy in autoimmune diseases. Front. Biosci. 12: 2546-2567.
14. O'Neill, S. K., M. J. Shlomchik, T. T. Giant, Y. Cao, P. D. Doodes, and A. Finnegan. 2005. Antigen-specific B cells are required as APCs and autoanti-body-producing cells for induction of severe autoimmune arthritis. J. Immunol. 174: 3781-3788.
15. Chan, O., L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189: 1639-1648.
16. Yan, J., B. P. Harvey, R. J. Gee, M. J. Shlomchik, and M. J. Mamula. 2006. B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J. Immunol. 177: 4481-4487.
17. + T cell priming in vivo. J. Immunol. 162: 5695-5703.
18. + T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J. Exp. Med. 203: 349-358.
19. Uchida, J., Y. Lee, M. Hasegawa, Y. Liang, A. Bradley, J. A. Oliver, K. Bowen, D. A. Steeber, K. M. Haas, J. C. Poe, and T. F. Tedder. 2004. Mouse CD20 expression and function. Int. Immunol. 16: 119-129.
20. Edwards, J. C., J. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D. R. Close, R. M. Stevens, and T. Shaw. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350: 2572-2581.
21. Edwards, J. C., and G. Cambridge. 2006. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol. 6: 394-403.
22. Martin, F., and A. C. Chan. 2004. Pathogenic roles of B cells in human autoimmunity: insights from the clinic. Immunity 20: 517-527.
23. Westermann, J., and R. Pabst. 1991. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system. Immunol. Today 11: 406-410.
24. Hamaguchi, Y., J. Uchida, D. W. Cain, G. M. Venturi, J. C. Poe, K. M. Haas, and T. F. Tedder. 2005. The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J. Immunol. 7: 4389-4399.
25. Gong, Q., Q. Ou, S. Ye, W. P. Lee, J. Cornelius, L. Diehl, W. Y. Lin, Z. Hu, Y. Lu, Y. Chen, et al. 2005. Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy. J. Immunol. 174: 817-826.
26. Minoru, H., Y. Hamaguchi, K. Yanaba, J. Bouaziz, J. Uchida, M. Fujimoto, T. Matsushita, Y. Matsushita, M. Horikawa, K. Komura, et al. 2006. B-lympho-cyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am. J. Pathol. 169: 954-966.
27. Hayakawa, I., T. F. Tedder, and Y. Zhuang. 2007. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 122: 73-79.
28. Yanaba, K., Y. Hamaguchi, G. M. Venturi, D. A. Steeber, E. W. St. Clair, and T. F. Tedder. 2007. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J. Immunol. 179: 1369-1380.
29. Ahuja, A., J. Shupe, R. Dunn, M. Kashgarian, M. R. Kehry, and M. J. Shlomchik. 2007. Depletion of B cells in murine lupus: efficacy and resistance. J. Immunol. 179: 3351-3361.
30. + T cell reactivity. J. Immunol. 180: 4994-5003.
31. Hu, C., D. Rodriguez-Pinto, W. Du, A. Ahuja, O. Henegariu, F. S. Wong, M. J. Schlomchik, and L. Wen. 2007. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117: 3857-3667.
32. + nonobese diabetic mice develop insulitis and diabetes. J. Exp. Med. 178: 793-803.
33. Brezinsky, S. C., G. G. Chiang, A. Szilvasi, S. Mohan, R. I. Shapiro, A. MacLean, W. Sisk, and G. Thill. 2003. A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J. Immunol. Methods 277: 141-155.
34. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-1196.
35. Silveira, P. A., H. D. Chapman, J. Stolp, E. Johnson, S. L. Cox, K. Hunter, L. S. Wicker, and D. Serreze. 2006. Genes within the Idd5 and Idd/11 diabetes susceptibility loci affect the pathogenic activity of B cells in nonobese diabetic mice. J. Immunol. 177: 7033-7041.
36. Evans, J. G., K. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
37. Uchida, J., Y. Hamaguchi, J. A. Oliver, J. V. Ravetch, J. C. Poe, K. M. Haas, and T. F. Tedder. 2004. The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J. Exp. Med. 199: 1659-1669.
38. Xiu, Y., C. P. Wong, J. Bouaziz, Y. Hamaguchi, Y. Wang, S. M. Pop, R. M. Tisch, and T. F. Tedder. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-spe-cific differences in FcγR effector functions. J. Immunol. 180: 2863-2875.
39. Looney, R. J., J. H. Anolik, D. Campbell, R. E. Felgar, F. Young, L. J. Arend, J. A. Sloand, J. Rosenblatt, and I. Sanz. 2004. B cell depletion as a novel treatment for systemic lupus erythematous: a phase I/II dose escalation trial of ritux-imab. Arthritis Rheum. 50: 2580-2589.
40. + T cell activation in mice. Proc. Natl. Acad. Sci. USA 104: 20878-20883.
41. Pritchard, N. R., A. J. Cutler, S. Uribe, S. J. Chadban, B. J. Morley, and K. G. Smith. 2000. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10: 227-230.
42. Prins, J. B., J. A. Todd, N. R. Rodriguez, S. Ghosh, P. M. Hogarth, L. S. Wicker, E. Gaffney, P. L. Podolin, P. A. Fischer, A. Airotina, and L. B. Peterson. 1993. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 260: 695-698.
43. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1: 147-153.
44. Mamula, M. J., and C. A. Janeway, Jr. 1993. Do B cells drive the diversification of immune response? Immunol. Today 14: 151-152.
45. Lin, R. H., M. J. Mamula, J. A. Hardin, and C. A. Janeway, Jr. 1991. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173: 1433-1439.
46. Dai, Y. D., G. Carayanniotis, and E. Sercarz. 2005. Antigen processing by autoreactive B cells promotes determinant spreading. Cell. Mol. Immunol. 2: 169-175.
47. Ansel, K. M., V. N. Ngo. P. L. Hyman, S. A. Luther, R. Forster, J. D. Sedgwick, J. L. Browning, M. Lipp, and J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309-314.
48. Fu, Y. X., and D. D. Chaplin. 1999. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17: 399-433.
49. Takemura, S., A. Braun, C. Crowson, P. J. Kurtin, R. H. Cofield, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167: 1072-1080.
50. Armengoi, M., M. Juan, A. Lucas-Martin, M. Teresa Femandez-Figueras, D. Jaraquemada, T. Gallart, and R. Pujol-Borell. 2001. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am. J. Pathol. 159: 861-873.
51. E1 Fassi, D., O. Clemmensen, C. H. Nielsen, R. Z. Silkiss, and L. Hegedus. 2007. Image in endocrinology: evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease. J. Clin. Endocrinol. Metab. 92: 3762-3763.
52. + T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Invest. 116: 2622-2629.
53. Aloisi, F., and R. Pujol-Borrell. 2006. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6: 205-217.
54. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
55. Olson, T. S., G. Bamias, M. Naganuma, J. Rivera-Nieves, T. L. Burcin, W. Ross, M. A. Morris, T. T. Pizarro, P. B. Emst, F. Cominelli, and K. Ley. 2004. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn diseases. J. Clin. Invest. 114: 389-398.
56. + T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA 102: 2010-2015.
57. Mauri, C., and M. R. Ehrenstein. 2008. The "short" history of regulatory B cells. Trends Immunol. 29: 34-40.
58. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
59. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderson. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
60. + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyetitis. J. Immunol. 178: 3447-3456.
61. Bour-Jordan, H., B. L. Salomon, H. L. Thompson, R. Santos, A. K. Abbas, and J. A. Bluestone. 2007. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J. Immunol. 179: 1004-1012.
62. Salvi, M., G. Vannucchi, I. Campi, N. Curro, D. Dazzi, S. Simonetta, P. Bonara, S. Rossi, C. Sina, C. Guastella, et al. 2007. Treatment of Graves' diseases and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur. J. Endocrinol. 156: 33-40.
63. Nielson, C. H., D. El Fassi, H. C. Hasselbalch, K. Bendtzen, and L. Hegedus. 2007. B-cell depletion'with rituximab in the treatment of autoimmune diseases: Graves' opthalmopathy the latest addition to an expanding family. Expert Opin, Biol. Ther. 7: 1061-1078.
64. Salvi, M., G. Vannucchi, I. Campi, N. Curro, D. Dazzi, S. Simonetta, P. Bonara, S. Rossi, C. Sina, C. Guastella, et al. 2007. Treatment of Graves' diseases and associated opthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur. J. Endocrinol. 156: 33-40.